ORECYCLINE

This brand name is authorized in Tunisia.

Active ingredients

The drug ORECYCLINE contains one active pharmaceutical ingredient (API):

`1`	Chlortetracycline UNII `WCK1KIQ23Q` - CHLORTETRACYCLINE
	Chlortetracycline is a tetracycline antibiotic isolated from Streptomyces aureofaciens. It has a role as an antiprotozoal drug, a fluorescent probe, a calcium ionophore and an antibacterial drug.
	Read more about Chlortetracycline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D06AA02	Chlortetracycline	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AA Tetracycline and derivatives
Discover more medicines within D06AA02
S01AA02	Chlortetracycline	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
TN	Direction de la Pharmacie et du Médicament	9000271, 9000281

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.